Stryker Buys Amplitude Vascular Systems As Valuation And Growth Weighed

Simply Wall St.04-15

Stryker (NYSE:SYK) has agreed to acquire Amplitude Vascular Systems, adding next generation intravascular lithotripsy technology to its portfolio. The deal expands Stryker's presence in vascular care ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2627422512?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/94614-main-header/1756253509683","is_english":true,"pubTime":"2026-04-15 04:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2627422512","market":"us","top_or_hot":-1,"title":"Stryker Buys Amplitude Vascular Systems As Valuation And Growth Weighed","media":"Simply Wall St.","content":"<div>\n<p>Stryker (NYSE:SYK) has agreed to acquire Amplitude Vascular Systems, adding next generation intravascular lithotripsy technology to its portfolio. The deal expands Stryker's presence in vascular care ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-syk/stryker/news/stryker-buys-amplitude-vascular-systems-as-valuation-and-gro\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stryker Buys Amplitude Vascular Systems As Valuation And Growth Weighed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStryker Buys Amplitude Vascular Systems As Valuation And Growth Weighed\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-15 04:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-syk/stryker/news/stryker-buys-amplitude-vascular-systems-as-valuation-and-gro><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stryker (NYSE:SYK) has agreed to acquire Amplitude Vascular Systems, adding next generation intravascular lithotripsy technology to its portfolio. The deal expands Stryker's presence in vascular care ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-syk/stryker/news/stryker-buys-amplitude-vascular-systems-as-valuation-and-gro\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GB00B4QBRK32.GBP","symbol_name":"FUNDSMITH EQUITY \"R\" (GBP) INC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-syk/stryker/news/stryker-buys-amplitude-vascular-systems-as-valuation-and-gro","article_id":"2627422512","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/94614-main-header/1756253509683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-syk/stryker/news/stryker-buys-amplitude-vascular-systems-as-valuation-and-gro","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2627422512","pubTimestamp":1776197230,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Stryker (NYSE:SYK) has agreed to acquire Amplitude Vascular Systems, adding next generation intravascular lithotripsy technology to its portfolio.\nThe deal expands Stryker's presence in vascular care and peripheral arterial disease treatments.\nThe acquisition introduces Stryker to the intravascular lithotripsy market, an area with ongoing product development and unmet clinical needs.\n\nStryker enters this transaction with its shares at $347.24 and a mixed recent return profile, including 4.5%...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"GB00B4QBRK32.GBP":"FUNDSMITH EQUITY \"R\" (GBP) INC","GB00B4LPDJ14.GBP":"FUNDSMITH EQUITY \"R\" (GBP) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","BK4585":"ETF&股票定投概念","LU2404859741.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) INC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU2404859667.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) ACC","BK4566":"资本集团","LU0690374961.EUR":"FUNDSMITH EQUITY \"R\" (EUR) INC","LU2506951875.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) ACC","LU0058720904.USD":"联博国际健康护理基金A","BK4082":"医疗保健设备","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","LU0690374615.EUR":"FUNDSMITH EQUITY \"R\" (EUR) ACC","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU2506952097.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (USDHDG) ACC","BK4504":"桥水持仓","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","LU0823417737.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) INC","LU2506951958.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) INC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","BK4588":"碎股","LU0950375773.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) INC A","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU0528227936.USD":"富达环球人口趋势基金A-ACC","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU2506952170.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (USDHDG) INC","SYK":"史赛克","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","AMPL":"AmplitudeE, Inc.","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","BK4023":"应用软件","LU0823417653.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) ACC","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD"},"translate_title":"Stryker因估值和增长权衡而收购Amplitude Vascular Systems","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMPL":1.5,"SYK":1.5},"content_text":"Stryker (NYSE:SYK) has agreed to acquire Amplitude Vascular Systems, adding next generation intravascular lithotripsy technology to its portfolio. The deal expands Stryker's presence in vascular care and peripheral arterial disease treatments. The acquisition introduces Stryker to the intravascular lithotripsy market, an area with ongoing product development and unmet clinical needs.  Stryker enters this transaction with its shares at $347.24 and a mixed recent return profile, including 4.5% over the past week and 42.4% over five years. For investors tracking NYSE:SYK, this move adds another dimension to an already established medical technology business that spans multiple therapeutic areas. The addition of Amplitude Vascular Systems gives Stryker a foothold in intravascular lithotripsy that aligns with its existing peripheral vascular and arterial disease tools. Investors may watch how quickly this technology integrates into Stryker's broader offering and how the company prioritizes resources between its newer vascular capabilities and its existing product lines. Stay updated on the most important news stories for Stryker by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Stryker. NYSE:SYK Earnings & Revenue Growth as at Apr 2026 📰 Beyond the headline: 2 risks and 3 things going right for Stryker that every investor should see. AdvertisementInvestor Checklist Quick Assessment  ✅ Price vs Analyst Target: At US$347.24, Stryker trades about 21% below the US$420.22 consensus price target. ⚖️ Simply Wall St Valuation: Shares are described as trading close to estimated fair value, so expectations around this deal may already be partly reflected. ✅ Recent Momentum: The stock has returned roughly 3.1% over the last 30 days.  There is only one way to know the right time to buy, sell or hold Stryker. Head to the Simply Wall St\ncompany report for the latest analysis of Stryker's Fair Value. Key Considerations  📊 The Amplitude Vascular Systems deal expands Stryker's vascular care offering, which could make its portfolio more comprehensive for peripheral arterial disease. 📊 Watch how the intravascular lithotripsy platform is commercialised, including adoption trends and any impact on Stryker's US$25.1b revenue base. ⚠️ Stryker already carries a relatively high P/E of 40.9 versus the medical equipment industry average of 26.6, so execution risk on new technology is important.  Dig Deeper For the full picture including more risks and rewards, check out the\ncomplete Stryker analysis. Alternatively, you can check out the\ncommunity page for Stryker to see how other investors believe this latest news will impact the company's narrative.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2627422512","isCrawlerRequest":true}